CD9 and chronic obstructive pulmonary disease: In the field of respiratory diseases, CD9 appears as a negative regulator of inflammation in COPD and the use of molecules, such as statins, upregulating tetraspanin CD9 in macrophages and allowing decreases of inflammation are under consideration (96) for therapeutic intervention.